Fairmount Funds Management »

Enliven Therapeutics shares owned by Fairmount Funds Management

Quarter-by-quarter ownership of Enliven Therapeutics (ELVN) shares owned by Fairmount Funds Management from 13F filings

Historical chart of Fairmount Funds Management investment in Enliven Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Enliven Therapeutics held by Fairmount Funds Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Enliven Therapeutics by Fairmount Funds Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $75M 3.2M 23.37
2024-03-31 $56M 3.2M 17.59
2023-12-31 $30M 2.1M 13.84
2023-09-30 $29M 2.1M 13.66
2023-06-30 $43M 2.1M 20.41
2023-03-31 $42M 1.9M 21.90